Therapies Development Targeting AI-2 Quorum Sensing of Enterobacterales

The understanding of AI-2 quorum sensing in Enterobacterales provides a basis for developing targeted therapies. Ace Therapeutics is committed to advancing the field through our comprehensive therapy development services. By harnessing the potential of AI-2 quorum sensing disruption, we strive to contribute to the global efforts in combating multidrug-resistant Enterobacterales infections.

Introduction to AI-2 Quorum Sensing of Enterobacterales

One of the key regulatory systems employed by Enterobacterales is AI-2 quorum sensing, which plays a crucial role in bacterial communication and virulence. AI-2 is a signaling molecule that enables inter-species communication, facilitating coordinated behaviors in bacterial communities.

AI-2 synthesis and perception in bacteria.Fig. 1 AI-2 synthesis and perception in bacteria. (Zhao J, et al., 2018)

Understanding the intricate mechanisms underlying AI-2 quorum sensing is paramount in developing effective therapies to combat Enterobacterales infections. By disrupting the quorum sensing pathways, we can potentially attenuate virulence, impair biofilm formation, and enhance the susceptibility of these pathogens to existing antibiotics.

Important Points Regarding Targeting AI-2 Quorum Sensing

  • Significance of AI-2 quorum sensing: In Enterobacterales, AI-2 quorum sensing regulates numerous processes, including virulence factor production, biofilm formation, and horizontal gene transfer.
  • Disrupting AI-2 quorum sensing: Various strategies have been explored to disrupt AI-2 quorum sensing, such as interfering with AI-2 synthesis, inhibiting AI-2 signaling receptors, and degrading AI-2 molecules. These approaches aim to attenuate the communication between bacteria and disrupt their coordinated behaviors.
  • Potential therapeutic applications: Targeting AI-2 quorum sensing presents a promising avenue for developing novel therapies against Enterobacterales infections. By interfering with bacterial communication, we can potentially render these pathogens more susceptible to existing antibiotics, preventing the formation of drug-resistant phenotypes.

Our Therapy Development Services

At Ace Therapeutics, we are at the forefront of therapies development targeting AI-2 quorum sensing in Enterobacterales. Our dedicated team of researchers and scientists utilize cutting-edge technologies and innovative approaches to identify and design potential therapeutics. Our services include:

AI-2 Inhibitor Screening

We employ high-throughput screening assays to identify compounds that can disrupt AI-2 quorum sensing in Enterobacterales. Our screening platforms enable us to rapidly assess the efficacy of potential inhibitors, facilitating the selection of lead compounds for further development.

Mechanism Elucidation

Understanding the precise mechanisms underlying AI-2 quorum sensing is crucial for designing effective therapies. Our team utilizes advanced molecular biology techniques and bioinformatics analyses to unravel the intricate signaling pathways involved in AI-2-mediated communication.

Therapeutic Development

Building upon the insights gained from AI-2 quorum sensing, we undertake the development of novel therapeutic approaches. This includes the design and synthesis of AI-2 inhibitors, formulation optimization, and preclinical evaluation to assess safety and efficacy.

Challenges and Future Directions

  • Resistance development - Continuous monitoring and surveillance are essential to identify emerging resistance patterns and develop strategies to overcome them.
  • In vivo efficacy - Optimizing drug delivery, bioavailability, and pharmacokinetic properties is crucial to ensure the effectiveness of therapies targeting AI-2 quorum sensing.
  • Combination therapies - Integrating AI-2 inhibitors with existing antibiotics or synergistic compounds could enhance treatment outcomes and prevent the emergence of resistance.

Looking ahead, the development of therapies targeting AI-2 quorum sensing holds immense promise in combating Enterobacterales infections. By leveraging the power of interdisciplinary research and collaborative efforts, we can pave the way for innovative strategies to mitigate the impact of multidrug-resistant pathogens. Contact us to advance your development project.


  1. Zhao J, et al. Production, detection and application perspectives of quorum sensing autoinducer-2 in bacteria. Journal of Biotechnology, 2018, 268: 53-60.
  2. Roy V, et al. Developing next generation antimicrobials by intercepting AI-2 mediated quorum sensing. Enzyme and microbial technology, 2011, 49(2): 113-123.
All of our services are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Get in touch with our team immediately.